Biochemical bone turnover markers are useful tools to assess changes in bone metabolism in marmosets

被引:0
作者
Anna Angeliewa
Michael Budde
Manfred Schlachter
Nicholas R. Hoyle
Frieder Bauss
机构
[1] F. Hoffmann-La Roche Ltd.,Department of Pharma Research, Animal Husbandry
[2] Free University of Berlin,Institute of Animal Protection, Behavior and Laboratory Animals
[3] F. Hoffmann-La Roche Ltd.,Pharma Development and Biostatistics
[4] Roche Vitamins Ltd.,Roche Diagnostics GmbH, Bone Metabolism & Anaemia
[5] Centralised Diagnostics,Roche Diagnostics GmbH, Pharma Research
[6] Bone Metabolism,Institute of Pharmacology and Toxicology
[7] Heidelberg University,undefined
来源
Journal of Bone and Mineral Metabolism | 2004年 / 22卷
关键词
biochemical markers of bone turnover; bone formation; bone resorption; ibandronate; marmosets; osteoporosis; metabolic bone diseases;
D O I
暂无
中图分类号
学科分类号
摘要
This study was designed to investigate whether biochemical markers of bone resorption and formation could be determined in the serum and urine of marmosets (Callithrix jacchus), using standard laboratory chemistry methods and commercially available human kits. Consequently, the findings from this study will indicate whether the techniques and kits could serve as appropriate tools for assessing changes in bone turnover in this species. Two groups of animals (n = 12/group), consisting of a comparable number of young and old male and female marmosets, were given either isotonic saline or a single dose of the bisphosphonate ibandronate (0.1 mg/kg) s.c. in order to suppress bone turnover. Blood and urine were collected at baseline and 5 days after administration. Samples were analyzed for urinary (u) and serum (s) markers of bone formation (serum osteocalcin [sOC], serum N-terminal crosslinks of human pro-collagen type I [sP1NP]) and bone resorption (urinary pyridinoline [uPYD], urinary deoxypyridinoline [uDPD], serum C-terminal crosslinks of human collagen type I (C-telopeptide) [sCTX]), intact serum parathyroid hormone (iPTH) and urinary calcium and creatinine. Levels of all the markers of bone resorption and formation decreased during the study period. As expected, the bone formation markers decreased slightly less relative to the resorption markers. The most sensitive markers were sCTX (−33%; P ≦ 0.001) for bone resorption, and sP1NP (−3%; P ≦ 0.05) for bone formation. Serum PTH levels increased by 8% (P ≦ 0.05), demonstrating a physiological reaction to prevent changes in serum calcium. Although not all variables reached statistical significance within the tested interval, the applied methods and kits were considered suitable for evaluating bone turnover changes in marmosets. Thus, these methods and kits can be utilized not only during the course of pharmacological investigations but also as additional tools to assess the overall bone health of this species.
引用
收藏
页码:192 / 197
页数:5
相关论文
共 50 条
[41]   Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004) [J].
Nishizawa, Y ;
Nakamura, T ;
Ohta, H ;
Kushida, K ;
Gorai, I ;
Shiraki, M ;
Fukunaga, M ;
Hosoi, T ;
Miki, T ;
Chaki, O ;
Ichimura, S ;
Nakatsuka, K ;
Miura, M .
JOURNAL OF BONE AND MINERAL METABOLISM, 2005, 23 (02) :97-104
[42]   Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001) [J].
Nishizawa, Y ;
Nakamura, T ;
Ohata, H ;
Kushida, K ;
Gorai, I ;
Shiraki, M ;
Fukunaga, M ;
Hosoi, T ;
Miki, T ;
Nakatsuka, K ;
Miura, M ;
Japan Osteoporosis Soc .
JOURNAL OF BONE AND MINERAL METABOLISM, 2001, 19 (06) :338-344
[43]   Bone turnover markers [J].
Coates, Penelope .
AUSTRALIAN FAMILY PHYSICIAN, 2013, 42 (05) :285-287
[44]   Biochemical markers of bone turnover during pregnancy: A longitudinal study [J].
Hellmeyer, L. ;
Ziller, V. ;
Anderer, G. ;
Ossendorf, A. ;
Schmidt, S. ;
Hadji, P. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (09) :506-510
[45]   Serum biochemical markers of bone turnover in healthy infants and children [J].
Tommasi, M ;
Bacciottini, L ;
Benucci, A ;
Brocchi, A ;
Passeri, A ;
Saracini, D ;
DAgata, A ;
Cappelli, G .
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1996, 11 (03) :159-164
[46]   Biochemical markers of bone turnover in aseptic loosening in hip arthroplasty [J].
Nikolaus A. Streich ;
Tobias Gotterbarm ;
Martin Jung ;
Ulrich Schneider ;
Christian Heisel .
International Orthopaedics, 2009, 33 :77-82
[47]   Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004) [J].
Yoshiki Nishizawa ;
Toshitaka Nakamura ;
Hiroaki Ohta ;
Kazuhiro Kushida ;
Itsuo Gorai ;
Masataka Shiraki ;
Masao Fukunaga ;
Takayuki Hosoi ;
Takami Miki ;
Osamu Chaki ;
Schoichi Ichimura ;
Kiyoshi Nakatsuka ;
Masakazu Miura .
Journal of Bone and Mineral Metabolism, 2005, 23 :97-104
[48]   Biochemical markers of bone turnover: preanalytical variability and recommendations for use [J].
Garnero, P ;
Bianchi, F ;
Carlier, MC ;
Genty, V ;
Jacob, N ;
Kamel, S ;
Kindermans, C ;
Plouvier, E ;
Pressac, M ;
Souberbielle, JC .
ANNALES DE BIOLOGIE CLINIQUE, 2000, 58 (06) :683-704
[49]   Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001) [J].
Yoshiki Nishizawa ;
Toshitaka Nakamura ;
Hiroaki Ohata ;
Kazuhiro Kushida ;
Itsuo Gorai ;
Masataka Shiraki ;
Masao Fukunaga ;
Takayuki Hosoi ;
Takami Miki ;
Kiyoshi Nakatsuka ;
Masakazu Miura .
Journal of Bone and Mineral Metabolism, 2001, 19 :338-344
[50]   Biochemical markers of bone turnover: Recent data and avenues for the future [J].
Garnero, P .
REVUE DU RHUMATISME, 1999, 66 (11) :538-542